October 7 visit of Bill Gates

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

1. 2013-09-26 22:17 Francis S. Collins open
   Dear colleagues, I am delighted you are able to join the roundtable discussion with Bill Gates on Monday, October 7, from 11:15 AM-12:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with staff from the Global Health Program at the BMGF. I had an opportunity to review the agenda briefly with Bill at the Lasker Awards ceremony (where he and Melinda received the Lakser~Bloomberg award) last week. He is very much looking forward to the discussion. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I also ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to relate the diverse scope of exciting science surrounding global health. Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD), and Kathy Young, Senior Project Manager for Strategic Planning and Engagement in Bill's office. Their bios area attached. We are delighted and honored that Eric Goosby (a former Barmes Lecturer) will join the roundtable. I am asking Eric to comment on the NIH/PEPFAR partnership in implementation science. We will include a working lunch as part of the roundtable discussion Details on the lunch are forthcoming. Prior to the discussion, we also will send a background summary of current IC (and FNIH) activities with the Gates Foundation. Rob Eiss of the FIC has assisted with the planning and organization of this visit. Please feel free to contact Rob with any questions you or your staff may have surrounding the visit. Best regards, Francis PROGRAM OF ACTIVITY NIH Visit OF BiLL GATES Octoser 7, 2013 10:15 AM-- 11:00 AM Media Roundtable at Clinical Center (room TBD) 11:05 AM - 11:15 AM Meeting with Dr. Collins (room TBD) 11:15 AM - 12:30 PM Roundtable Discussion with NIH Senior Leadership Medical Board Room, Clinical Center Opening remarks: Francis Collins and Bill Gates Select priorities in global health R&D: state of the science, question to resolve e --HlVand malaria vaccines, and other prevention technologies Lead discussant: Hugh Auchincloss, Principal Deputy Director, NIAID Cliff Lane, Deputy Director for Clinical Research, NIAID Roger Glass, Director, FIC e Understanding the molecular basis of growth and nutrition Lead discussant: Alan Guttmacher, Director, NICHD Greg Germino, Director NIDDK ¢ Point-of-care diagnostics and therapeutics for neglected diseases Lead discussant: Roderic Pettigrew, Director, NIBIB Martha Somerman. Director, NIDCR Chris Austin, Director, NCATS e Integrating NCDs into global health Lead Discussant: Harold Varmus, Director, NCI Gary Gibbons, Director, NHLBI e New partnerships in discovery science: H3Africa and MEPI, the BRAIN initiative Lead Discussant: Eric Green, Director, NHGRI Francis Collins Roger Glass e NIH-PEPAR Implementation Science Partnership Eric Goosby, US Global AIDS Coordinator 12:00 PM-12:30 PM Working Lunch Masur Auditorium, Clinical Center 1:00 PM - 2:00 PM David E. Barmes Global Health Lecture 1:00 PM--- 1:05 PM Introduction by Dr. Collins 1:05 PM -- 1:40 PM Lecture 1:40 PM -- 2:00 PM Q's and A's The C.W. "Bill" Young Center 2:20 PM -- 3:05 PM Innovations in TB Drug Development Clif Barry 3:05 PM -- 3:20 PM Wrap up discussion Dr. Collins and Mr. Gates Chris Wilson Bill and Melinda Gates Foundation Dr. Chris Wilson, director of the Global Health Discovery & Translational Sciences program, leads a team that targets fundamental scientific and technological advances in global health that could lead to new ways to prevent, treat, and diagnose disease. Wilson joined the foundation in 2009 as Deputy Director, Vaccine Discovery and Human Biology, Global Health Discovery. Wilson is a pediatrician and immunologist. He joined the faculty at the University of Washington in 1979 in the Infectious Diseases Division of the Department of Pediatrics and later served as head of the Division of Infectious Diseases, Immunology and Rheumatology. In 1989, he became one of the founding faculty members in the new Department of Immunology, and served as Chairman of the Department of Immunology and head of the graduate program in immunology from 1999-2009. He has also served on a number of national advisory panels, including the Institute of Medicine Vaccine Safety Review Committee (2001-2004) and the National Advisory Council on Child Health and Human Development, the NIH Advisory Committee to the Director, and he co-chaired the NIAID US Immunodeficiency Network Pilot Grant Review Committee. He is an elected fellow of the American Association for the Advancement of Science. Wilson received a bachelor's degree from the University of California, Irvine and a medical degree from UCLA. He trained in pediatrics at Boston Children's Hospital /Harvard Medical School, served in the US Public Health Service, and then was a post-doctoral fellow in infectious diseases while performing immunology research at Stanford University. Kathleen Young Bill and Melinda Gates Foundation Prior to joining the Gates Foundation in 1997, Kathy worked for the Paul Allen Group (the personal investment vehicle for Paul G. Allen, co-founder of Microsoft) for three years. Before relocating to Seattle in 1994, Kathy spent 10 years in the Washington D.C. area working for the Fairfax County Chamber of Commerce and a residential building firm based in Bethesda, Maryland. Kathy, a graduate of IIlinois's Parkland College, now resides in Kirkland, Washington.
2. 2013-09-26 22:17 Francis S. Collins open
   Dear colleagues, I am delighted you are able to join the roundtable discussion with Bill Gates on Monday, October 7, from 11:15 AM-12:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with staff from the Global Health Program at the BMGF. I had an opportunity to review the agenda briefly with Bill at the Lasker Awards ceremony (where he and Melinda received the Lakser~Bloomberg award) last week. He is very much looking forward to the discussion. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I also ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to relate the diverse scope of exciting science surrounding global health. Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD), and Kathy Young, Senior Project Manager for Strategic Planning and Engagement in Bill's office. Their bios area attached. We are delighted and honored that Eric Goosby (a former Barmes Lecturer) will join the roundtable. I am asking Eric to comment on the NIH/PEPFAR partnership in implementation science. We will include a working lunch as part of the roundtable discussion Details on the lunch are forthcoming. Prior to the discussion, we also will send a background summary of current IC (and FNIH) activities with the Gates Foundation. Rob Eiss of the FIC has assisted with the planning and organization of this visit. Please feel free to contact Rob with any questions you or your staff may have surrounding the visit. Best regards, Francis PROGRAM OF ACTIVITY NIH Visit OF BiLL GATES Octoser 7, 2013 10:15 AM-- 11:00 AM Media Roundtable at Clinical Center (room TBD) 11:05 AM - 11:15 AM Meeting with Dr. Collins (room TBD) 11:15 AM - 12:30 PM Roundtable Discussion with NIH Senior Leadership Medical Board Room, Clinical Center Opening remarks: Francis Collins and Bill Gates Select priorities in global health R&D: state of the science, question to resolve e --HlVand malaria vaccines, and other prevention technologies Lead discussant: Hugh Auchincloss, Principal Deputy Director, NIAID Cliff Lane, Deputy Director for Clinical Research, NIAID Roger Glass, Director, FIC e Understanding the molecular basis of growth and nutrition Lead discussant: Alan Guttmacher, Director, NICHD Greg Germino, Director NIDDK ¢ Point-of-care diagnostics and therapeutics for neglected diseases Lead discussant: Roderic Pettigrew, Director, NIBIB Martha Somerman. Director, NIDCR Chris Austin, Director, NCATS e Integrating NCDs into global health Lead Discussant: Harold Varmus, Director, NCI Gary Gibbons, Director, NHLBI e New partnerships in discovery science: H3Africa and MEPI, the BRAIN initiative Lead Discussant: Eric Green, Director, NHGRI Francis Collins Roger Glass e NIH-PEPAR Implementation Science Partnership Eric Goosby, US Global AIDS Coordinator 12:00 PM-12:30 PM Working Lunch Masur Auditorium, Clinical Center 1:00 PM - 2:00 PM David E. Barmes Global Health Lecture 1:00 PM--- 1:05 PM Introduction by Dr. Collins 1:05 PM -- 1:40 PM Lecture 1:40 PM -- 2:00 PM Q's and A's The C.W. "Bill" Young Center 2:20 PM -- 3:05 PM Innovations in TB Drug Development Clif Barry 3:05 PM -- 3:20 PM Wrap up discussion Dr. Collins and Mr. Gates Chris Wilson Bill and Melinda Gates Foundation Dr. Chris Wilson, director of the Global Health Discovery & Translational Sciences program, leads a team that targets fundamental scientific and technological advances in global health that could lead to new ways to prevent, treat, and diagnose disease. Wilson joined the foundation in 2009 as Deputy Director, Vaccine Discovery and Human Biology, Global Health Discovery. Wilson is a pediatrician and immunologist. He joined the faculty at the University of Washington in 1979 in the Infectious Diseases Division of the Department of Pediatrics and later served as head of the Division of Infectious Diseases, Immunology and Rheumatology. In 1989, he became one of the founding faculty members in the new Department of Immunology, and served as Chairman of the Department of Immunology and head of the graduate program in immunology from 1999-2009. He has also served on a number of national advisory panels, including the Institute of Medicine Vaccine Safety Review Committee (2001-2004) and the National Advisory Council on Child Health and Human Development, the NIH Advisory Committee to the Director, and he co-chaired the NIAID US Immunodeficiency Network Pilot Grant Review Committee. He is an elected fellow of the American Association for the Advancement of Science. Wilson received a bachelor's degree from the University of California, Irvine and a medical degree from UCLA. He trained in pediatrics at Boston Children's Hospital /Harvard Medical School, served in the US Public Health Service, and then was a post-doctoral fellow in infectious diseases while performing immunology research at Stanford University. Kathleen Young Bill and Melinda Gates Foundation Prior to joining the Gates Foundation in 1997, Kathy worked for the Paul Allen Group (the personal investment vehicle for Paul G. Allen, co-founder of Microsoft) for three years. Before relocating to Seattle in 1994, Kathy spent 10 years in the Washington D.C. area working for the Fairfax County Chamber of Commerce and a residential building firm based in Bethesda, Maryland. Kathy, a graduate of IIlinois's Parkland College, now resides in Kirkland, Washington.
3. 2013-09-26 22:17 Francis S. Collins
   Dear colleagues, I am delighted you are able to join the roundtable discussion with Bill Gates on Monday, October 7, from 11:15 AM-12:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with staff from the Global Health Program at the BMGF. I had an opportunity to review the agenda briefly with Bill at the Lasker Awards ceremony (where he and Melinda received the Lakser~Bloomberg award) last week. He is very much looking forward to the discussion. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I also ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to relate the diverse scope of exciting science surrounding global health. Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD), and Kathy Young, Senior Project Manager for Strategic Planning and Engagement in Bill's office. Their bios area attached. We are delighted and honored that Eric Goosby (a former Barmes Lecturer) will join the roundtable. I am asking Eric to comment on the NIH/PEPFAR partnership in implementation science. We will include a working lunch as part of the roundtable discussion Details on the lunch are forthcoming. Prior to the discussion, we also will send a background summary of current IC (and FNIH) activities with the Gates Foundation. Rob Eiss of the FIC has assisted with the planning and organization of this visit. Please feel free to contact Rob with any questions you or your staff may have surrounding the visit. Best regards, Francis
4. 2013-09-26 22:17 Francis S. Collins open
   Dear colleagues, I am delighted you are able to join the roundtable discussion with Bill Gates on Monday, October 7, from 11:15 AM-12:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with staff from the Global Health Program at the BMGF. I had an opportunity to review the agenda briefly with Bill at the Lasker Awards ceremony (where he and Melinda received the Lakser~Bloomberg award) last week. He is very much looking forward to the discussion. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I also ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to relate the diverse scope of exciting science surrounding global health. Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD), and Kathy Young, Senior Project Manager for Strategic Planning and Engagement in Bill's office. Their bios area attached. We are delighted and honored that Eric Goosby (a former Barmes Lecturer) will join the roundtable. I am asking Eric to comment on the NIH/PEPFAR partnership in implementation science. We will include a working lunch as part of the roundtable discussion Details on the lunch are forthcoming. Prior to the discussion, we also will send a background summary of current IC (and FNIH) activities with the Gates Foundation. Rob Eiss of the FIC has assisted with the planning and organization of this visit. Please feel free to contact Rob with any questions you or your staff may have surrounding the visit. Best regards, Francis meb 3/10/23 isdn ss a cabin praia nieces ang 1 communities in Zarb and South Alc. The intervention, taking place in PEPFAR funded ns in he intervention communities, s scheduled to begin by September 30, Enoment nthe population coor (hich fl be ued to measure the HI inince outcome gin next moth POC CD testing with streaming ination of care in Ugands, roe ssid pare ciation evs ina 38 actin Kea str candomied i fe SAMAK FOC voi et to improve Stevenson sso (compared to stand eeare SOC} on nage cra retenion of HV pote puters For pata esting tet seb 3/10/13 ays recat Noh Central igen Yotebeing uptake and retention of PMTCT serves Repub of Congo eactsaned ! 75000 to WHO PMTCT gudeines a South os wat metnadoiogyformensurng PMTCT owes I ge, ety lant gross sd HI esting and SRS ale BESS TOTAL pee, z i : [Simin i a js ao Ri Fa z Ee : Sa0o0, i Bic ii igen Siac ailing rg Ung Ropu: K Cabstcn wih PEBFAA i : - : : wo SS P laphang idea aaaaca T i F oa omen I nen Methadone aa Sabonne for ectng a PEPFAR onding was sapped all these pat unded ough NDA - i i aia eaicion Bari inane : = E = :
5. 2013-09-26 22:17 Francis S. Collins open
   Dear colleagues, lam delighted you are able to join the roundtable discussion with Bill Gates on Monday, October 7, from 11:15 AM-12:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with staff from the Global Health Program at the BMGF. I had an opportunity to review the agenda briefly with Bill at the Lasker Awards ceremony (where he and Melinda received the Lakser~Bloomberg award) last week. He is very much looking forward to the discussion. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I also ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to relate the diverse scope of exciting science surrounding global health. Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD), and Kathy Young, Senior Project Manager for Strategic Planning and Engagement in Bill's office. Their bios area attached. We are delighted and honored that Eric Goosby (a former Barmes Lecturer) will join the roundtable. I am asking Eric to comment on the NIH/PEPFAR partnership in implementation science. We will include a working lunch as part of the roundtable discussion Details on the lunch are forthcoming. Prior to the discussion, we also will send a background summary of current IC (and FNIH) activities with the Gates Foundation. Rob Eiss of the FIC has assisted with the planning and organization of this visit. Please feel free to contact Rob with any questions you or your staff may have surrounding the visit. Best regards, Francis
6. 2013-09-26 22:17 Francis S. Collins open
   Dear colleagues, I am delighted you are able to join the roundtable discussion with Bill Gates on Monday, October 7, from 11:15 AM-12:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with staff from the Global Health Program at the BMGF. I had an opportunity to review the agenda briefly with Bill at the Lasker Awards ceremony (where he and Melinda received the Lakser~Bloomberg award) last week. He is very much looking forward to the discussion. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I also ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to relate the diverse scope of exciting science surrounding global health. Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD), and Kathy Young, Senior Project Manager for Strategic Planning and Engagement in Bill's office. Their bios area attached. We are delighted and honored that Eric Goosby (a former Barmes Lecturer) will join the roundtable. I am asking Eric to comment on the NIH/PEPFAR partnership in implementation science. We will include a working lunch as part of the roundtable discussion Details on the lunch are forthcoming. Prior to the discussion, we also will send a background summary of current IC (and FNIH) activities with the Gates Foundation. Please feel free to contact Rob with any Rob Eiss of the FIC has assisted with the planning and organization of this visit. Please feel free to contact Rob with any questions you or your staff may have surrounding the visit. Best regards, Francis Would Melanie Bacon by the person In that you comment 1) the state of 2d discussion. 2eping flexible ry, this format
7. 2013-09-26 22:17 Francis S. Collins open
   Dear colleagues, I am delighted you are able to join the roundtable discussion with Bill Gates on Monday, October 7, from 11:15 AM-12:30 PM, to take place in the Medical Board Room of the NIH Clinical Center. Attached is the program for the visit, outlining the agenda for the roundtable discussion. The topics are based on conversations with staff from the Global Health Program at the BMGF. I had an opportunity to review the agenda briefly with Bill at the Lasker Awards ceremony (where he and Melinda received the Lakser~Bloomberg award) last week. He is very much looking forward to the discussion. Based on Bill's preferences, we are organizing the roundtable as a conversation, rather than series of presentations. In order to make best use of available time, I have identified lead discussants for each agenda topic. I ask that you comment briefly, not to exceed 3 minutes, on one or several select scientific challenges of relevance to the BMGF: 1) the state of current knowledge and 2) the important questions to resolve. The comments would be intended to seed discussion. Unless you have compelling reasons to include powerpoints, I would suggest avoiding those for this informal conversation. I will try to ensure we cover as much of the agenda as feasible in the time available, while keeping flexible and responsive to Bill's interests and the flow of discussion. Could I also ask lead discussants to confer with colleagues identified under their area, to discuss how to share the time allocated to introduce topics? Given Bill's extensive knowledge in global health R&D and scientific savvy, this format should work well and allow us to relate the diverse scope of exciting science surrounding global health. yject Manager for Strategic Planning and Engagement in lam asking Eric to Details on the lunch are forthcoming. Please feel free to contact Rob with any Bill will be joined at the roundtable by Chris Wilson, Director of the Global Health Discovery & Translational Sciences program (and a member of the ACD), and Kathy Young, Senior Project Manager for Strategic Planning and Engagement in Bill's office. Their bios area attached. We are delighted and honored that Eric Goosby (a former Barmes Lecturer) will join the roundtable. I am asking Eric to comment on the NIH/PEPFAR partnership in implementation science. We will include a working lunch as part of the roundtable discussion Details on the lunch are forthcoming. Prior to the discussion, we also will send a background summary of current IC (and FNIH) activities with the Gates Foundation. Rob Eiss of the FIC has assisted with the planning and organization of this visit. Please feel free to contact Rob with any questions you or your staff may have surrounding the visit. Best regards, Francis Would Melanie Bacon by the person

Full conversation →